G Luzzatto - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

G Luzzatto

Showing results (31-40 of 36) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 36 results.

Seminars in Thrombosis and Hemostasis|January 1, 1997

Tissue factor pathway inhibitor (TFPI) antigen plasma level in patients with interstitial lung disease before and after heparin administrationG Cella, A Cipriani, A Tommasini, et al.

Haematologica|January 1, 1989

The use of fluorescence flow cytometry in the characterization of Bernard-Soulier syndrome and Glanzmann's thrombastheniaF Fabris, A Casonato, M L Randi, et al.

Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988

The prevalence of AIDS, AIDS related complex and HIV seropositivity in a large population of patients with congenital clotting disordersA Girolami, G Luzzatto, R Dal Bo Zanon, et al.

British Journal of Haematology|March 22, 2001

Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpuraF Fabris, T Tassan, R Ramon, et al.

Seminars in Thrombosis and Hemostasis|January 1, 1997

Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients: effect of hyperinsulinemiaG Cella, R Vettor, A Sbarai, et al.

Hematology (Amsterdam, Netherlands)|July 14, 2016

The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with ThrombocytosisG Cella, J Conard, S Manai, et al.

Pageof 4

Search research articles

Showing results (31-40 of 36) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 36 results.

Seminars in Thrombosis and Hemostasis|January 1, 1997

Tissue factor pathway inhibitor (TFPI) antigen plasma level in patients with interstitial lung disease before and after heparin administrationG Cella, A Cipriani, A Tommasini, et al.

Haematologica|January 1, 1989

The use of fluorescence flow cytometry in the characterization of Bernard-Soulier syndrome and Glanzmann's thrombastheniaF Fabris, A Casonato, M L Randi, et al.

Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1988

The prevalence of AIDS, AIDS related complex and HIV seropositivity in a large population of patients with congenital clotting disordersA Girolami, G Luzzatto, R Dal Bo Zanon, et al.

British Journal of Haematology|March 22, 2001

Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpuraF Fabris, T Tassan, R Ramon, et al.

Seminars in Thrombosis and Hemostasis|January 1, 1997

Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients: effect of hyperinsulinemiaG Cella, R Vettor, A Sbarai, et al.

Hematology (Amsterdam, Netherlands)|July 14, 2016

The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with ThrombocytosisG Cella, J Conard, S Manai, et al.

Pageof 4